SCD patients displayed an increased population of circulating monocytes expressing high levels of HO-1 with anti-inflammatory properties (37% vs. 7% in controls), and could be involved in removing hemolysis-damaged endothelial cells, thus confirming the key role of circulant cells expressing HO-1 [131]. Here, HMOX1 is linked to Schnyder corneal dystrophy.